Skip to main content
SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,850
-150 (-0.35%)
At close: May 28, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Vaccine/Biopharmaceuticals
369.51B
Log In
Log In
Log In
Log In
Upgrade
Vaccine/Biopharmaceuticals Growth
-19.10%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
America
185.96B
Log In
Log In
Log In
Log In
Upgrade
America Growth
-14.63%
Log In
Log In
Log In
Log In
Upgrade
South Korea
158.22B
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-29.42%
Log In
Log In
Log In
Log In
Upgrade
Europe
21.20B
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
53.88%
Log In
Log In
Log In
Log In
Upgrade
Asia
3.89B
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
497.76%
Log In
Log In
Log In
Log In
Upgrade
Middle East
231.61M
Log In
Log In
Log In
Log In
Upgrade
Middle East Growth
-24.07%
Log In
Log In
Log In
Log In
Upgrade